These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12092462)

  • 21. Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials.
    Staeva TP; Chatenoud L; Insel R; Atkinson MA
    Diabetes; 2013 Jan; 62(1):9-17. PubMed ID: 23258904
    [No Abstract]   [Full Text] [Related]  

  • 22. Outlook for immune intervention in type I diabetes.
    Grob PJ
    Curr Probl Clin Biochem; 1983; 12():119-40. PubMed ID: 6360542
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of autoimmune diabetes by mycophenolate mofetil is associated with down-regulation of TH1 cytokine-induced apoptosis in the target tissue.
    Stosic-Grujicic S; Maksimovic-Ivanic D; Miljkovic D; Trajkovic V; Lukic M; Mostarica Stojkovic M
    Transplant Proc; 2002 Nov; 34(7):2955-7. PubMed ID: 12431671
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin-dependent diabetes: now for some good news.
    Harrison L
    Med J Aust; 1996 Nov; 165(9):466-7. PubMed ID: 8937363
    [No Abstract]   [Full Text] [Related]  

  • 25. Specific therapeutic attempts in experimental and clinical type-I diabetes.
    Federlin K; Becker F
    Klin Wochenschr; 1990; 68 Suppl 21():38-43. PubMed ID: 2198389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiazolidinediones may not reduce diabetes incidence in type 1 diabetes.
    Shigihara T; Okubo Y; Kanazawa Y; Oikawa Y; Shimada A
    Ann N Y Acad Sci; 2006 Oct; 1079():365-8. PubMed ID: 17130580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Summary of a workshop on immunosuppression in the management of type I diabetes mellitus (IDDM).
    Diabetes Research Program, National Institutes of Health
    N Engl J Med; 1983 Nov; 309(19):1199-200. PubMed ID: 6621673
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclophosphamide inhibits the development of diabetes in the diabetes-prone BB rat.
    Sobel DO; Ahvazi B; Jun HS; Chung YH; Yoon JW
    Diabetologia; 2000 Aug; 43(8):986-94. PubMed ID: 10990075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type I insulin dependent diabetes: an autoimmune disease that can be arrested or prevented with immunotherapy?
    Winter WE; Maclaren NK
    Adv Pediatr; 1985; 32():159-75. PubMed ID: 3909773
    [No Abstract]   [Full Text] [Related]  

  • 31. Interleukin-13 prevents autoimmune diabetes in NOD mice.
    Zaccone P; Phillips J; Conget I; Gomis R; Haskins K; Minty A; Bendtzen K; Cooke A; Nicoletti F
    Diabetes; 1999 Aug; 48(8):1522-8. PubMed ID: 10426368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future.
    Rewers M; Gottlieb P
    Diabetes Care; 2009 Oct; 32(10):1769-82. PubMed ID: 19794002
    [No Abstract]   [Full Text] [Related]  

  • 33. [Etiology and pathogenesis of type I diabetes].
    Ziegler AG
    Z Gesamte Inn Med; 1993 Mar; 48(3):100-7. PubMed ID: 8475631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen Therapy Delays Autoimmune Diabetes and Promotes the Protective Efficiency of Natural Killer T-Cell Activation in Female Nonobese Diabetic Mice.
    Gourdy P; Bourgeois EA; Levescot A; Pham L; Riant E; Ahui ML; Damotte D; Gombert JM; Bayard F; Ohlsson C; Arnal JF; Herbelin A
    Endocrinology; 2016 Jan; 157(1):258-67. PubMed ID: 26485613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against autoimmune diabetes by induction of mixed bone marrow chimerism.
    Mathieu C; Vandeputte M; Bouillon R; Waer M
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1266-7. PubMed ID: 8442108
    [No Abstract]   [Full Text] [Related]  

  • 36. Update on global intervention studies in type 1 diabetes.
    Chiang JL; Haller MJ; Schatz DA
    Endocrinol Metab Clin North Am; 2012 Dec; 41(4):695-712. PubMed ID: 23099265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of autoimmune destruction of transplanted islets in spontaneously diabetic NOD mice by KH1060, a 20-epi analog of vitamin D: synergy with cyclosporine.
    Mathieu C; Laureys J; Waer M; Bouillon R
    Transplant Proc; 1994 Dec; 26(6):3128-9. PubMed ID: 7998092
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside.
    Bresson D; von Herrath M
    Diabetes Care; 2009 Oct; 32(10):1753-68. PubMed ID: 19794001
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosis and treatment of pre-insulin dependent diabetes.
    Gottlieb PA; Eisenbarth GS
    Annu Rev Med; 1998; 49():391-405. PubMed ID: 9509271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice.
    Zheng XX; Steele AW; Hancock WW; Stevens AC; Nickerson PW; Roy-Chaudhury P; Tian Y; Strom TB
    J Immunol; 1997 May; 158(9):4507-13. PubMed ID: 9127018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.